113 related articles for article (PubMed ID: 21921332)
1. Platelet enzyme abnormalities in leukemias.
Sharma S; Purohit A; Pati HP; Kochupillai V
Indian J Cancer; 2011; 48(3):323-7. PubMed ID: 21921332
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte enzyme abnormalities in leukemias.
Sharma S; Pati HP
J Assoc Physicians India; 2006 Jun; 54():453-7. PubMed ID: 16909693
[TBL] [Abstract][Full Text] [Related]
3. Red cell enzymopathies in leukemias.
Devi GS; Prasad MH; Pushpavathi K; Reddy PP; Rao DN
Indian J Exp Biol; 1996 Dec; 34(12):1224-8. PubMed ID: 9246916
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte glucose 6 phosphate dehydrogenase as prognostic indicator in ANLL and CML.
Devi GS; Prasad MH; Reddy PP; Rao DN
Indian J Exp Biol; 1997 Feb; 35(2):155-8. PubMed ID: 9315224
[TBL] [Abstract][Full Text] [Related]
5. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
6. [Study on correlation and clinical significance of superoxide dismutase (SOD) activity and content in 102 patients with leukemia].
Zhu CS; Zhang CY; Weng WQ
Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):39-42. PubMed ID: 8033747
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
8. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
9. Platelet function in acute leukemias.
Naresh KN; Sivasankaran P; Veliath AJ
J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
12. Blood viscosity parameter correlation with types of leukemia.
Sharma K; Puniyani RR; Bhat SV; Advani SH; Hegde U; Rao S
Physiol Chem Phys Med NMR; 1992; 24(2):159-64. PubMed ID: 1508991
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
14. [Hexokinase activity of erythrocytes in cancer patients].
Sensini A; Braussi M; Spadoni M; Giacchi R
Quad Sclavo Diagn; 1981 Dec; 17(4):431-7. PubMed ID: 7347823
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.
Veiga Cde S; Carneiro-Lobo TC; Coelho CJ; Carvalho SM; Maia RC; Vasconcelos FC; Abdelhay E; Mencalha AL; Ferreira AF; Castro FA; Monteiro RQ
Blood Cells Mol Dis; 2011 Mar; 46(3):230-4. PubMed ID: 21216163
[TBL] [Abstract][Full Text] [Related]
16. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Trenn G; Schmidt O; Nahler M; Schaefer UW
Bone Marrow Transplant; 1999 Apr; 23(8):771-7. PubMed ID: 10231138
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
18. Red cell enzymes in acute leukemia in relapse & remission.
Kochupillai V; Scott CW; Moreno H; Gams RA
Indian J Med Res; 1983 Sep; 78():377-83. PubMed ID: 6585349
[No Abstract] [Full Text] [Related]
19. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
